Non-replicating expression vectors: applications in vaccine development and gene therapy-Reference-Cited by-同舟云学术

Non-replicating expression vectors: applications in vaccine development and gene therapy

Published:1996-06 Issue:3 Volume:116 Page:241-256
ISSN:0950-2688
Container-title:Epidemiology and Infection
language:en
Short-container-title:Epidemiol. Infect.

Author:

Limbach K. J.,Paoletti E.

Abstract

SUMMARYThis review presents experimental, preclinical and clinical data illustrating the multiple uses of recombinant non-replicating virus vectors in the fields of immunoprophylaxis and gene therapy.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Epidemiology

Reference87 articles.

1. Protection of chickens with a recombinant fowlpox virus expressing the newcastle disease virus hemagglutinin-neuraminidase gene

2. Induction of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Cytolytic T Lymphocyte Responses in Seronegative Adults by a Nonreplicating, Host-Range-Restricted Canarypox Vector (ALVAC) Carrying the HIV-1MN env Gene

3. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

4. Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 Vaccines: An Overview of Different Platforms;Bioengineering;2022-02-12

2. Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition;PLOS Pathogens;2020-03-12

3. Synthetic DNA vaccine strategies against persistent viral infections;Expert Review of Vaccines;2013-05

4. Immunoprophylaxis against important virus diseases of horses, farm animals and birds;Vaccine;2009-03

5. Inactivation of Adenovirus Type 5 by Caustics;Biotechnology Progress;2008-09-05